Stay updated on Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.

Latest updates to the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page
- CheckyesterdayChange DetectedA clinical study report synopsis, sponsor-related items (AbbVie), and a new 'Helpful Links Provided by AbbVie' section were added, and the page revision was updated to v3.5.4.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe ClinicalTrials.gov page’s footer version indicator has been updated from Revision v3.5.2 to Revision v3.5.3.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No changes to the page content or clinical information are indicated.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page.SummaryDifference0.1%

- Check94 days agoChange DetectedA new site revision entry v3.4.2 was added, and notices about governmental funding and the previous revision v3.4.1 were removed. These changes are administrative in nature and do not affect the study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.